GYL Financial Synergies’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $347K | Sell |
8,492
-12,266
| -59% | -$501K | 0.03% | 276 |
|
|
2024
Q2 | $799K | Sell |
20,758
-229
| -1% | -$8.82K | 0.06% | 196 |
|
|
2024
Q1 | $900K | Sell |
20,987
-417
| -2% | -$17.9K | 0.07% | 192 |
|
|
2023
Q4 | $793K | Sell |
21,404
-12
| -0.1% | -$445 | 0.07% | 200 |
|
|
2023
Q3 | $776K | Sell |
21,416
-1,100
| -5% | -$39.9K | 0.08% | 198 |
|
|
2023
Q2 | $802K | Buy |
22,516
+13,624
| +153% | +$486K | 0.07% | 196 |
|
|
2023
Q1 | $316K | Sell |
8,892
-172
| -2% | -$6.12K | 0.04% | 234 |
|
|
2022
Q4 | $319K | Buy |
9,064
+71
| +0.8% | +$2.5K | 0.07% | 171 |
|
|
2022
Q3 | $265K | Buy |
+8,993
| New | +$265K | 0.07% | 162 |
|
|
2022
Q2 | – | Sell |
-5,038
| Closed | -$274K | – | 197 |
|
|
2022
Q1 | $274K | Buy |
+5,038
| New | +$274K | 0.07% | 164 |
|
|
2020
Q3 | – | Sell |
-4,214
| Closed | -$215K | – | 160 |
|
|
2020
Q2 | $215K | Buy |
+4,214
| New | +$215K | 0.16% | 140 |
|
|
2020
Q1 | – | Sell |
-4,450
| Closed | -$261K | – | 160 |
|
|
2019
Q4 | $261K | Buy |
4,450
+548
| +14% | +$32.1K | 0.12% | 150 |
|
|
2019
Q3 | $208K | Buy |
+3,902
| New | +$208K | 0.1% | 163 |
|